Literature DB >> 33973218

A Borderless Solution Is Needed for A Borderless Complexity, Like COVID-19, the Universal Invader.

Kawthar Mohamed1,2, Rangarirai Makuku1,3, Eduardo Rodríguez-Román4,5, Aram Pascal Abu Hejleh6,7, Musa Joya8,9,10, Mariya Ivanovska11,12,13, Sara A Makka14,15, Md Shahidul Islam16,17, Nesrine Radwan18,19, Attig-Bahar Faten20,21, Chunfeng Xiao22, Leander Marquez23,24, Nima Rezaei25,26.   

Abstract

This chapter briefly describes the universal intricacies caused by the COVID-19 pandemic, from the ineffectiveness of distance measures, the massive economic impacts, and the severe mental health challenges to the failure of finding a vaccine, a therapeutic agent or even accurately diagnosing the infection. The entire world is suffering, but every country is trying to combat this pandemic individually, and this deed is the main barrier that prevents reaching a peaceful end.

Entities:  

Keywords:  Borderless; COVID-19; Complexity; Pandemic; Solution; Universe

Mesh:

Year:  2021        PMID: 33973218     DOI: 10.1007/978-3-030-63761-3_50

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  26 in total

1.  Genetic Predictors of Depressive Symptoms in the Look AHEAD Trial.

Authors:  Jeanne M McCaffery; George D Papandonatos; Lucy F Faulconbridge; Bahar Erar; Inga Peter; Lynne E Wagenknecht; Nicholas M Pajewski; Andrea Anderson; Thomas A Wadden; Rena R Wing
Journal:  Psychosom Med       Date:  2015 Nov-Dec       Impact factor: 4.312

2.  Defining the Epidemiology of Covid-19 - Studies Needed.

Authors:  Marc Lipsitch; David L Swerdlow; Lyn Finelli
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

3.  Fourteenth Annual Symposium on Advanced Analytical Concepts for the Clinical Laboratory. Proceedings.

Authors: 
Journal:  Clin Chem       Date:  1982-09       Impact factor: 8.327

Review 4.  Lymphopenia in COVID-19: Therapeutic opportunities.

Authors:  Nazanin Fathi; Nima Rezaei
Journal:  Cell Biol Int       Date:  2020-06-03       Impact factor: 3.612

5.  COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being.

Authors:  Bobak Moazzami; Niloofar Razavi-Khorasani; Arash Dooghaie Moghadam; Ermia Farokhi; Nima Rezaei
Journal:  J Clin Virol       Date:  2020-04-04       Impact factor: 3.168

6.  Covid-19 - Navigating the Uncharted.

Authors:  Anthony S Fauci; H Clifford Lane; Robert R Redfield
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Authors:  Shohei Koyama; Esra A Akbay; Yvonne Y Li; Grit S Herter-Sprie; Kevin A Buczkowski; William G Richards; Leena Gandhi; Amanda J Redig; Scott J Rodig; Hajime Asahina; Robert E Jones; Meghana M Kulkarni; Mari Kuraguchi; Sangeetha Palakurthi; Peter E Fecci; Bruce E Johnson; Pasi A Janne; Jeffrey A Engelman; Sidharta P Gangadharan; Daniel B Costa; Gordon J Freeman; Raphael Bueno; F Stephen Hodi; Glenn Dranoff; Kwok-Kin Wong; Peter S Hammerman
Journal:  Nat Commun       Date:  2016-02-17       Impact factor: 14.919

8.  The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.

Authors:  Amir Hossein Mansourabadi; Mona Sadeghalvad; Hamid-Reza Mohammadi-Motlagh; Nima Rezaei
Journal:  Life Sci       Date:  2020-08-01       Impact factor: 5.037

9.  Genetic predisposition models to COVID-19 infection.

Authors:  Farzaneh Darbeheshti; Nima Rezaei
Journal:  Med Hypotheses       Date:  2020-05-06       Impact factor: 1.538

Review 10.  Monoclonal antibody as a potential anti-COVID-19.

Authors:  Leila Jahanshahlu; Nima Rezaei
Journal:  Biomed Pharmacother       Date:  2020-06-04       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.